ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $583,267 | -68.3% | 21,707 | -58.0% | 0.01% | -64.3% |
Q2 2023 | $1,842,695 | +48.7% | 51,674 | +5.9% | 0.01% | +27.3% |
Q1 2023 | $1,239,088 | +64068.2% | 48,783 | +2.4% | 0.01% | -31.2% |
Q4 2022 | $1,931 | -99.9% | 47,617 | +13.5% | 0.02% | +14.3% |
Q3 2022 | $1,387,000 | -5.9% | 41,967 | +0.3% | 0.01% | -12.5% |
Q2 2022 | $1,474,000 | -17.1% | 41,859 | +8.3% | 0.02% | -11.1% |
Q1 2022 | $1,778,000 | -22.4% | 38,650 | +11.8% | 0.02% | -25.0% |
Q4 2021 | $2,292,000 | +6.6% | 34,567 | +0.4% | 0.02% | -4.0% |
Q3 2021 | $2,150,000 | -25.1% | 34,444 | -0.7% | 0.02% | -21.9% |
Q2 2021 | $2,872,000 | +25.1% | 34,675 | +0.1% | 0.03% | +14.3% |
Q1 2021 | $2,296,000 | -12.8% | 34,626 | +0.9% | 0.03% | -24.3% |
Q4 2020 | $2,633,000 | +86.5% | 34,314 | +4.7% | 0.04% | +32.1% |
Q3 2020 | $1,412,000 | +51.8% | 32,785 | +52.3% | 0.03% | +64.7% |
Q2 2020 | $930,000 | +37.2% | 21,531 | -8.6% | 0.02% | +13.3% |
Q1 2020 | $678,000 | -39.5% | 23,551 | +33.4% | 0.02% | -25.0% |
Q4 2019 | $1,120,000 | +22.9% | 17,657 | -45.4% | 0.02% | +25.0% |
Q3 2019 | $911,000 | +5.8% | 32,325 | -0.5% | 0.02% | +6.7% |
Q2 2019 | $861,000 | – | 32,473 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |